4//SEC Filing
Easom Eric 4
Accession 0000899243-22-035311
CIK 0001880438other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 8:19 PM ET
Size
14.6 KB
Accession
0000899243-22-035311
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-11-03$15.67/sh−11,082$173,683→ 29,021 total - Sale
Common Stock
2022-11-04$15.80/sh−8,828$139,474→ 17,110 total - Sale
Common Stock
2022-11-07$15.90/sh−10,167$161,705→ 6,943 total - Sale
Common Stock
2022-11-03$16.02/sh−3,083$49,376→ 25,938 total - Sale
Common Stock
2022-11-07$16.72/sh−2,036$34,036→ 4,907 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914503
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 8:19 PM ET
- Size
- 14.6 KB